ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,187.70
0.13%
US Tech 100
17,617.63
0.04%
다우존스 지수
38,884.26
0.08%
Bitcoin
62,625.69
0.47%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Innate Pharma SA (IPHA)

  7. Innate Pharma SA (IPHA) 뉴스

IPHA Innate Pharma SA

2.57
0.08 (3.21%)
08 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Innate Pharma SA IPHA 나스닥 주식예탁증서 (DR)
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.08 3.21% 2.57 06:12:55
개장가 저가 고가 종가 전일 종가
2.52 2.48 2.57 2.57 2.49
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
07/05/202414:00BWInnate Pharma organise une conférence téléphonique pour..
15/04/202414:00BWInnate Pharma to Hold Its Annual General Meeting of..
10/04/202414:00BWInnate Pharma présente des données d’efficacité précliniques..
09/04/202414:00BWInnate Pharma Announces Its Participation in Upcoming..
05/04/202416:34BWInnate Pharma publie son Document D’enregistrement Universel..
21/03/202415:00BWInnate Pharma Reports Full Year 2023 Financial Results and..
19/03/202415:00BWInnate Pharma annonce sa participation à une prochaine..
14/03/202415:00BWInnate Pharma Announces Conference Call and Webcast for Full..
06/03/202415:00BWInnate Pharma: First Patient dosed in Phase 1/2 study of..
21/02/202415:00BWInnate Pharma Announces Its Participation to Upcoming..
17/01/202414:15EDGAR2Form EFFECT - Notice of Effectiveness
12/01/202420:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/01/202415:00BWNouveau nombre d’actions et de droits de vote d’Innate..
05/01/202420:09EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/01/202420:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/01/202420:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/01/202415:00BWInnate Pharma Announces U.S. FDA Lifts Partial Clinical Hold..
04/01/202414:59BWInnate Pharma renforce son équipe de direction et nomme deux..
21/12/202306:45EDGAR2Form F-3 - Registration statement by foreign private issuers
21/12/202306:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19/12/202321:28DJNInnate Pharma Shares Rise after Sanofi Exercises Licensing..
19/12/202315:00BWInnate Pharma annonce la licence d’un quatrième NK Cell..
18/12/202315:00BWInnate Pharma Announces Leadership Change
11/12/202315:00BWInnate Pharma partage les résultats d’efficacité et de..
10/12/202315:00BWInnate Pharma Presents Positive Results From TELLOMAK Phase..
27/11/202315:00BWInnate Pharma to Host Virtual KOL Event on Lacutamab
14/11/202315:00BWInnate Pharma présente ses résultats financiers au troisième..
07/11/202315:00BWInnate Pharma organise une conférence téléphonique pour ses..
03/11/202319:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/11/202315:00BWInnate Pharma annonce la présentation de nouvelles données..
27/10/202319:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/10/202314:00BWInnate Pharma annonce sa participation à de prochaines..
19/10/202319:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19/10/202314:00BWInnate Pharma 2024 Financial Calendar
16/10/202314:00BWInnate Pharma Announces Abstracts Selected for ESMO Congress..
09/10/202314:00BWNouveau nombre d’actions et de droits de vote d’Innate..
05/10/202321:14DJNInnate Pharma Shares Fall Premarket on FDA Partial Study..
05/10/202314:00BWInnate Pharma annonce une mise à jour sur le programme..
22/09/202314:00BWInnate Pharma présente les données d’efficacité..
14/09/202319:27EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/09/202319:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/09/202314:00BWInnate Pharma présente ses résultats financiers et l’avancée..
29/08/202319:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/08/202314:00BWInnate Pharma annonce sa participation à de prochaines..
10/08/202314:00BWProchain rendez-vous investisseurs d'Innate Pharma
11/07/202319:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/07/202314:00BWFirst Patient Dosed in SAR’514 / IPH6401 Phase 1/2 Clinical..
07/07/202319:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/07/202314:00BWNouveau nombre d’actions et de droits de vote d’Innate..
26/06/202314:00BWInnate Pharma : Traitement du premier patient dans l’essai..

최근 히스토리

NASDAQ
IPHA
Innate Pharma
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유